RPG Life Sciences

RPG Life Sciences Q1 Revenue Rises 2.1% YoY to ₹168.9 Cr

RPG Life Sciences announces Q1 FY26 results: Revenue up 2.1% YoY to ₹168.9 Cr with 24.1% EBITDA margin. PBT stable at ₹35.4 Cr. Exploring inorganic growth for accelerated expansion.